Developing medicinal product with AI: From an idea to clinical licensing (White Paper)
Artificial intelligence offers enormous potential in drug research and development. Its use is not only promising, but also makes it possible to identify potential drugs, improve safety and efficiency throughout the entire development process and also pave the way for personalized treatment approaches. The white paper provides an overview of the potential and challenges of using AI technologies along the entire drug development process and shows the important contribution AI can make to innovative solutions.
